Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2b1b54f50a3ca3323f279860b5382c2d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5df3dcb3ec7746d05b2c5f2d5a59b998 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80f30ccb3ccf2ae671b34d6a9b1d164b |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1234 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1272 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1271 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-133 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-12 |
filingDate |
2004-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1c5acd196d7714f2101a742464b1277 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f230265a0eb8a9f1a44ea60898158715 |
publicationDate |
2004-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2004082626-A2 |
titleOfInvention |
Aromatase inhibitor diagnosis and therapy |
abstract |
The present invention provides pharmaceutical compositions which are useful for imaging and/or treating endometriosis. The compositions are useful for the treatment of reproductive age women, as well as post-menopausal women suffering from this disorder. The pharmaceutical composition is a liposome composition that includes a liposome carrier component that contains on its surface a moiety targeted for an endometriotic implant or leaky blood vessels within the implant. The inventive liposome composition includes an aromatase inhibitor and/or a radiolabeled complex encapsulated by the liposome component. A label capable of external detection can be included so as to permit the detection of an endometrial implant and/or diagnosis of the presence of endornetriosis in a patient. The label can be bound to the aromatase inhibitor. Alternatively, when the label is separate from the inhibitor, or when the inhibitor is not present, a radiolabeled complex can be included. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11192903-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633357-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011006510-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010272957-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8920775-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10556916-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102920658-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265269-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2453927-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9993427-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2481587-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9226984-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2453927-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102920658-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012079582-A1 |
priorityDate |
2003-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |